Department of Nephrology, Hospital Clínic, Barcelona, Spain.
Dirección Médica, Fresenius Medical Care, Madrid, Spain.
Am J Nephrol. 2017;46(4):288-297. doi: 10.1159/000481669. Epub 2017 Oct 17.
BACKGROUND: The majority of studies suggesting that online hemodiafiltration reduces the risk of mortality compared to hemodialysis (HD) have been performed in dialysis-prevalent populations. In this report, we conducted an epidemiologic study of mortality in incident dialysis patients, comparing post-dilution online hemodiafiltration and high-flux HD, with propensity score matching (PSM) used to correct indication bias. METHODS: Our study cohort comprised 3,075 incident dialysis patients treated in 64 Spanish Fresenius Medical Care clinics between January 2009 and December 2012. The primary outcome of this study was to investigate the impact of the type of renal replacement on all-cause mortality. An analysis of cardiovascular mortality was defined as the secondary outcome. To achieve these objectives, patients were followed until December 2016. Patients were categorized as high-flux HD patients if they underwent this treatment exclusively. If >90% of their treatment was with online hemodiafiltration, then the patient was grouped to that modality. RESULTS: After PSM, a total of 1,012 patients were matched. Compared with patients on high-flux HD, those on online hemodiafiltration received a median replacement volume of 23.45 (interquartile range 21.27-25.51) L/session and manifested 24 and 33% reductions in all-cause and cardiovascular mortality (all-cause mortality hazards ratio [HR] 0.76, 95% CI 0.62-0.94 [p = 0.01]; and cardiovascular mortality HR 0.67, 95% CI 0.50-0.90 [p = 0.008]). CONCLUSIONS: This study shows that post-dilution online hemodiafiltration reduces all-cause and cardiovascular mortality compared to high-flux HD in an incident HD population.
背景:大多数表明在线血液透析滤过(HFHD)比血液透析(HD)降低死亡率风险的研究都是在透析流行人群中进行的。在本报告中,我们对新进入透析的患者进行了死亡率的流行病学研究,比较了后稀释在线 HFHD 和高通量 HD,并使用倾向评分匹配(PSM)纠正适应证偏倚。
方法:我们的研究队列包括 2009 年 1 月至 2012 年 12 月在西班牙 Fresenius 医疗保健 64 家诊所接受治疗的 3075 名新进入透析的患者。本研究的主要结局是调查肾脏替代治疗类型对全因死亡率的影响。心血管死亡率分析被定义为次要结局。为了实现这些目标,患者随访至 2016 年 12 月。如果患者仅接受高通量 HD 治疗,则将其归类为高通量 HD 患者。如果他们的治疗中 >90%是在线 HFHD,则将患者分组到该模式。
结果:经过 PSM 后,共匹配了 1012 名患者。与高通量 HD 患者相比,接受在线 HFHD 的患者接受的中位置换量为 23.45(四分位间距 21.27-25.51)L/次,全因死亡率和心血管死亡率分别降低了 24%和 33%(全因死亡率危害比 [HR]0.76,95%CI0.62-0.94[P=0.01];心血管死亡率 HR0.67,95%CI0.50-0.90[P=0.008])。
结论:本研究表明,在后稀释在线 HFHD 与新进入 HD 人群中的高通量 HD 相比,全因和心血管死亡率降低。
Korean J Intern Med. 2014-11
Clin J Am Soc Nephrol. 2009-10-9
J Am Soc Nephrol. 2012-4-26
BMC Nephrol. 2015-10-30
J Bras Nefrol. 2024
Membranes (Basel). 2022-6-15
Kidney360. 2020-12-30
Kidney Res Clin Pract. 2022-11